We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
DySIS Medical Appoints Chairman
News

DySIS Medical Appoints Chairman

DySIS Medical Appoints Chairman
News

DySIS Medical Appoints Chairman

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DySIS Medical Appoints Chairman"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Mr. Cascella was previously Chief Executive Officer and President of Hologic Inc., a leading manufacturer and supplier of diagnostic products, medical imaging systems, and surgical products for Women’s Healthcare, between 2003 and 2013. He has over 30 years of senior management, operational and finance experience. Prior to Hologic, Mr. Cascella served as Managing Partner of CFG Capital LLC, an investment banking firm specialising in healthcare and was the Chief Operating Officer and Vice President of Finance at NeoVision Corporation, a developer of 3D ultrasound technology used for real-time guidance of interventional breast procedures.

Alastair Atkinson, CEO of DySIS Medical, said: “We welcome Robert as Chairman. His industry knowledge, market and technology expertise and extensive connections in the Women’s Healthcare industry add substantial value to our team. I look forward to working with him to move DySIS into the next stage of growth and expansion.

“I look forward to working with Alastair and the team on the commercialisation strategy of a technology capable of significantly improving upon the diagnostic protocols for cervical disease,” Mr. Cascella added. “DySIS has the unique opportunity to increase the effectiveness of the current standard of care in developed markets, while potentially addressing an unmet healthcare need in emerging markets, where the diagnosis and treatment of cervical disease remains woefully inadequate.”

DySIS Medical, a medical devices company active within Women’s Health, has developed an advanced cervical scan which, in addition to performing traditional colposcopy examinations, uses dynamic spectral imaging to scan, quantify and map the cervix.

Advertisement